What drove global government bond performance in a year characterised by changing monetary policy, shifting yield curves and volatile currencies? In 2025, long-duration government bonds delivered ...

In this new FX thriller created by Ryan Murphy, being drop-dead gorgeous comes with a cost. Titled "The Beauty," the body horror series based on a comic book is about a "sexually transmitted virus ...

Writing from the Chicagoland area in Illinois, Robert is an avid movie watcher and will take just about any excuse to find time to go to his local movie theaters. Robert graduated from Bradley ...

Emerging market currency activity grew at double the pace of developed market currencies from April 2022 to April 2025. With the launch of services like CME Group’s FX Tape+, the industry is moving ...

U.S. inflation data for December will likely be the highlight of the week as investors continue to gauge the likely timing and extent of further interest-rate cuts by the Federal Reserve. In Europe, ...

Ethan Hawke will reprise his role as a Tulsa “truthstorian” in the drama from Sterlin Harjo. By Rick Porter Television Business Editor FX will continue to follow the exploits of Tulsa, Oklahoma ...

2025 was a big year for cybersecurity, with major cyberattacks, data breaches, threat groups reaching new notoriety levels, and, of course, zero-day vulnerabilities exploited in incidents. Some ...

A politically motivated assassination shocked the world. President Donald Trump’s return to the White House reshaped the nation. White smoke billowed from the Sistine Chapel chimney as the papal ...

Forbes contributors publish independent expert analyses and insights. I cover the intersection of people, risk, leadership and performance. This voice experience is generated by AI. Learn more. This ...

It's been a great year for movies. Revisit the best of the best, already on Netflix, HBO Max, and more. 2025 has come to an end, and with it comes a lot of reflection, both in terms of how the world ...

Matthew Herper covers medical innovation — both its promise and its perils. It has been a tough year for medicine. The U.S. research enterprise has been scrambled by a series of political decisions ...